Lamotrigin Orion (Lamotrigine)

Lamotrigine works by inhibiting voltage‑gated sodium channels on neuronal membranes, which reduces the release of excitatory neurotransmitters such as glutamate. This action dampens abnormal electrical firing in the brain, helping to control seizures and stabilise mood in bipolar disorder.

The specific dose of Lamotrigin Orion is determined by the prescribing clinician based on the patient’s condition, age, renal and hepatic function, and any concomitant medications. Dosage titration follows established clinical guidelines, and patients should follow the prescriber’s instructions precisely.

Lamotrigin Orion is classified as Pregnancy Category B, indicating that animal studies have not shown risk but there are limited human data. It may be used during pregnancy only if the potential benefit justifies the risk. Limited data are available for breastfeeding; a prescriber should evaluate the risk‑benefit ratio for each individual.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Compared with older anticonvulsants such as carbamazepine or phenytoin, lamotrigine offers a broader spectrum of seizure control and a favourable side‑effect profile, particularly regarding cognitive effects. However, it requires careful titration to minimise rash risk and may interact more strongly with enzyme‑inducing drugs, necessitating individualized dosing.

Lamotrigin Orion should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging to protect it from moisture and light. Do not store in areas with high humidity or direct sunlight, and keep out of reach of children.

Lamotrigin Orion is taken orally, usually as a tablet, with or without food as directed by the prescriber. The medication is typically started at a low dose and gradually increased to the therapeutic dose to reduce the risk of rash. Swallow the tablet whole with water; do not crush or chew unless instructed otherwise.

The most serious risks include severe skin reactions such as Stevens‑Johnson syndrome and toxic epidermal necrolysis, as well as rare blood disorders like aplastic anemia. Patients should seek immediate medical attention if they develop widespread rash, blistering, fever, or signs of infection.

Lamotrigin Orion is contraindicated in individuals with a known hypersensitivity to lamotrigine or any of its excipients. Caution is also advised for patients with severe hepatic or renal impairment, and those taking interacting medications such as valproic acid without appropriate dose adjustments.